Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.66
Delayed Data
As of Jul 22
 -0.04 / -1.48%
Today’s Change
2.30
Today|||52-Week Range
5.30
-45.04%
Year-to-Date
3 Top Stocks Under $5
Jul 18 / MotleyFool.com - Paid Partner Content
Geron (GERN) Gets Three Patents for Imetelstat in the U.S.
Jul 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.70
Today’s open2.70
Day’s range2.64 - 2.71
Volume861,525
Average volume (3 months)1,869,006
Market cap$422.8M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratio9,399.3
Price/Sales21.65
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.17+1.39%
--Quidel Corp-0.29-1.63%
ALRPRBAlere Inc+9.98+2.93%
QDELQuidel Corp-0.09-0.46%
Data as of 4:06pm ET, 07/22/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs